cysteamine has been researched along with Corneal Diseases in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Csorba, A; Kelen, K; Maka, E; Nagy, ZZ; Reusz, G; Szabó, A | 1 |
| Bowman, MA; Casanova, MI; Chokshi, TJ; Cosert, K; Daley, NL; Gragg, MM; Kang, J; Leonard, BC; Mccorkell, ME; Minella, AL; Murphy, CJ; Raghunathan, VK; Thomasy, SM | 1 |
| Avti, P; Bhattacharyya, A; Bhattacharyya, J; Das, D; Kaur, H; Kaur, S; Kumar, S; Medhi, B; Prajapat, M; Prakash, A; Ram, J; Sarma, P; Shekhar, N; Singh, R | 1 |
| Baudouin, C; Labbé, A; Le Mouhaër, J; Liang, H; Plisson, C | 1 |
| Aktas, Z; Hasanreisoglu, M; Ozdemir, HB; Özmen, MC | 1 |
| Chauhan, A; Dixon, P | 1 |
| Ribeiro, AC; Ribeiro, L; Saraiva, E; Sequeira, J; Sousa-Neves, F; Varandas, R | 1 |
| Berryhill, A; Bhamre, S; Chaudhuri, A; Concepcion, W; Grimm, PC | 1 |
| Ariceta, G; Camacho, JA; Fernández-Obispo, M; Fernández-Polo, A; Gamez, J; García-Villoria, J; Güell, A; Lara Monteczuma, E; Leyes, P; Martín-Begué, N; Morell, GP; Oppenheimer, F; Perelló, M; Santandreu, AV; Torra, R | 1 |
| Bozdağ, S; Gümüş, K; Gümüş, O; Unlü, N | 1 |
| Bazaraa, H; El-Baroudy, R; Rizk, A; Soliman, NA; Younan, A | 1 |
| Coelho, D; Macário, MC; Murta, J; Quadrado, MJ; Tavares, R; Torres, A | 1 |
| Buchan, B; Cairns, D; Heneghan, A; Kay, G; Matthews, KH | 1 |
| Grupcheva, CN; McGhee, C; Ormonde, SE | 1 |
| Del Monte, M; Gahl, W; Granet, DB; Kaiser-Kupfer, MI; Lindblad, AS; Reed, GF; Rubin, B; Schneider, JA; Thoene, J; Thompson, D; Tsilou, ET | 1 |
| Khan, AO; Latimer, B | 1 |
| Gräf, M; Kalinowski, HO | 1 |
| Jones, NP; Noble, JL; Postlethwaite, RJ | 1 |
| Caruso, RC; Datiles, MB; Gahl, WA; Gazzo, MA; Kaiser-Kupfer, MI; Kuehl, EM | 1 |
| Raub, W | 1 |
| Fujikawa, L; Gahl, WA; Jain, S; Kaiser-Kupfer, MI; Kuwabara, T | 1 |
1 review(s) available for cysteamine and Corneal Diseases
| Article | Year |
|---|---|
Efficacy and Safety of Topical Cysteamine in Corneal Cystinosis: A Systematic Review and Meta-Analysis.
Topics: Corneal Diseases; Cysteamine; Cystine Depleting Agents; Cystinosis; Humans; Ophthalmic Solutions; Visual Acuity | 2021 |
4 trial(s) available for cysteamine and Corneal Diseases
| Article | Year |
|---|---|
A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study.
Topics: Adolescent; Cornea; Corneal Diseases; Cysteamine; Cystine; Cystine Depleting Agents; Cystinosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Microscopy, Confocal; Ophthalmic Solutions; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Young Adult | 2017 |
A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis.
Topics: Administration, Topical; Adolescent; Adult; Child; Child, Preschool; Corneal Diseases; Cysteamine; Cystinosis; Double-Blind Method; Female; Humans; Male; Prospective Studies; Radiation-Protective Agents; Treatment Outcome | 2003 |
A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis.
Topics: Adolescent; Adult; Child; Child, Preschool; Corneal Diseases; Crystallization; Cysteamine; Cystinosis; Double-Blind Method; Female; Humans; Infant; Male; Ophthalmic Solutions; Randomized Controlled Trials as Topic | 1990 |
Removal of corneal crystals by topical cysteamine in nephropathic cystinosis.
Topics: Administration, Topical; Adolescent; Age Factors; Animals; Corneal Diseases; Crystallization; Cysteamine; Cystinosis; Female; Humans; In Vitro Techniques; Infant; Kidney Diseases; Male; Ophthalmic Solutions; Rabbits | 1987 |
16 other study(ies) available for cysteamine and Corneal Diseases
| Article | Year |
|---|---|
Ocular treatment of cystinosis with eye drop containing cysteamine
Topics: Cornea; Corneal Diseases; Cysteamine; Cystine; Cystinosis; Humans; Photophobia; Quality of Life; Visual Acuity | 2022 |
The TGM2 inhibitor cysteamine hydrochloride does not impact corneal epithelial and stromal wound healing in vitro and in vivo.
Topics: Animals; Cicatrix; Cornea; Corneal Diseases; Corneal Injuries; Cysteamine; Cystinosis; Epithelium, Corneal; Protein Glutamine gamma Glutamyltransferase 2; Rabbits; Wound Healing | 2023 |
Topics: Adult; Anterior Eye Segment; Cornea; Corneal Diseases; Crystallization; Cysteamine; Cystine Depleting Agents; Cystinosis; Female; Follow-Up Studies; Humans; Microscopy, Confocal; Ophthalmic Solutions; Tomography, Optical Coherence; Visual Acuity | 2019 |
Carbon Black Tinted Contact Lenses for Reduction of Photophobia in Cystinosis Patients.
Topics: Animals; Antihypertensive Agents; Contact Lenses, Hydrophilic; Corneal Diseases; Cysteamine; Cystine Depleting Agents; Cystinosis; Drug Delivery Systems; Elastic Modulus; Microscopy, Electron, Scanning; Photophobia; Rabbits; Refractometry; Soot; Spectrophotometry, Ultraviolet; Timolol; Vitamin E; Vitamins | 2019 |
Ocular manifestations of intermediate cystinosis: To treat or not to treat?
Topics: Adult; Cornea; Corneal Diseases; Cysteamine; Cystine Depleting Agents; Cystinosis; Female; Follow-Up Studies; Humans; Microscopy, Confocal; Slit Lamp Microscopy; Time Factors; Tomography, Optical Coherence; Visual Acuity | 2020 |
Cysteamine in renal transplantation: A report of two patients with nephropathic cystinosis and the successful re-initiation of cysteamine therapy during the immediate post-transplant period.
Topics: Adolescent; Child; Corneal Diseases; Cysteamine; Cystinosis; Drug Administration Schedule; Fanconi Syndrome; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Inpatients; Kidney Transplantation; Male; Postoperative Period; Renal Insufficiency; Tacrolimus; Treatment Outcome | 2016 |
Cystinosis in adult and adolescent patients: Recommendations for the comprehensive care of cystinosis.
Topics: Adolescent; Adult; Amino Acid Transport Systems, Neutral; Comprehensive Health Care; Corneal Diseases; Cysteamine; Cystinosis; Disease Management; Early Diagnosis; Endocrine System Diseases; Genetic Counseling; Humans; Interdisciplinary Communication; Kidney Failure, Chronic; Kidney Transplantation; Nervous System Diseases; Patient Education as Topic; Quality of Life; Self Care; Transition to Adult Care | 2015 |
Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
Topics: Administration, Topical; Adult; Animals; Benzalkonium Compounds; Chemistry, Pharmaceutical; Corneal Diseases; Cysteamine; Cystinosis; Drug Administration Schedule; Drug Stability; Excipients; Eye; Female; Hot Temperature; Humans; Hydrogen-Ion Concentration; Hypromellose Derivatives; Kinetics; Male; Methylcellulose; Ophthalmic Solutions; Orphan Drug Production; Osmolar Concentration; Preservatives, Pharmaceutical; Rabbits; Solubility; Sterilization; Toxicity Tests, Acute; Viscosity | 2008 |
Nephropathic cystinosis in children: An overlooked disease.
Topics: Administration, Oral; Administration, Topical; Child; Child, Preschool; Cornea; Corneal Diseases; Cysteamine; Cystinosis; Diagnostic Techniques, Ophthalmological; Disease Progression; Fanconi Syndrome; Female; Humans; Infant; Kidney Failure, Chronic; Male; Medication Adherence; Ophthalmic Solutions; Predictive Value of Tests; Severity of Illness Index; Treatment Outcome | 2009 |
Evaluation of treatment with cysteamine eyedrops for cystinosis with confocal microscopy.
Topics: Corneal Diseases; Crystallization; Crystallography; Cysteamine; Cystine; Cystinosis; Drug Administration Schedule; Female; Humans; Kidney Diseases; Kidney Transplantation; Medical Records; Microscopy, Confocal; Ophthalmic Solutions; Photophobia; Treatment Outcome; Visual Acuity; Young Adult | 2009 |
Gel formulations for treatment of the ophthalmic complications in cystinosis.
Topics: Acrylic Resins; Adhesiveness; Animals; Cattle; Cornea; Corneal Diseases; Cysteamine; Cystinosis; Drug Carriers; Drug Compounding; Gels; Hydrogen-Ion Concentration; In Vitro Techniques; Molecular Structure; Phenylalanine; Rheology; Solubility | 2010 |
In vivo confocal microscopy of the cornea in nephropathic cystinosis.
Topics: Adult; Cornea; Corneal Diseases; Crystallization; Cysteamine; Cystinosis; Humans; Kidney Diseases; Male; Microscopy, Confocal | 2002 |
Successful use of topical cysteamine formulated from the oral preparation in a child with keratopathy secondary to cystinosis.
Topics: Administration, Topical; Capsules; Chemistry, Pharmaceutical; Child; Corneal Diseases; Cysteamine; Cystinosis; Humans; Male; Ophthalmic Solutions; Pharmaceutical Preparations; Photophobia; Retrospective Studies | 2004 |
[1H-NMR spectroscopic study of cysteamine eyedrops].
Topics: Cornea; Corneal Diseases; Cystamine; Cysteamine; Cystinosis; Dose-Response Relationship, Drug; Drug Stability; Humans; Magnetic Resonance Spectroscopy; Ophthalmic Solutions; Oxidation-Reduction | 1995 |
Clearance of corneal crystals in nephropathic cystinosis by topical cysteamine 0.5%.
Topics: Administration, Topical; Child, Preschool; Cornea; Corneal Diseases; Crystallization; Cysteamine; Cystinosis; Female; Humans | 1991 |
From the National Institutes of Health.
Topics: Corneal Diseases; Cysteamine; Cystinosis; Growth Hormone; Humans; Lymphocyte Activation; National Institutes of Health (U.S.); Paraparesis, Tropical Spastic; Prednisone; Protein Deficiency; United States | 1990 |